Celsis International - Rule 8 Disclosure
14 May 1998 - 11:16PM
UK Regulatory
RNS No 4680q
CELSIS INTERNATIONAL PLC
Date of Disclosure....14th May 1998......
DISCLOSURE UNDER RULES 8.1(a), 8.1(b)(i) and 8.3
OF THE CITY CODE ON TAKE-OVERS AND MERGERS
Date of dealing....13th May 1998....
Dealing in..Celsis International Plc.......................(name of company)
(1) Class of securities (eg ordinary shares)..Ord GBP 0.01................
(2) Amount bought Amount sold Price per unit
50,000 #0.45
(3) Resultant total of the same class owned or controlled
(and percentage of class)....4,583,065............................. (4.60%)
(4) Party making disclosure....Standard Life Assurance Company..............
(5) EITHER (a) Name of purchaser/vendor (Note 1)Standard Life Assurance Co...
OR (b) if dealing for discretionary client(s), name of fund management
organisation
............................N/A................................................
(6) Reason for disclosure (Note 2)
(a) associate of (i) offeror (Note 3) NO
(ii) offeree company NO
Specify which category or categories of associate (1-8 overleaf)....N/A........
If category (8), explain.........N/A............................................
................................................................................
(b) Rule 8.3 (ie disclosure because of ownership or control of 1% or more
of the class of relevant securities dealt in) YES
Signed, for and on behalf of the party named in (4) above......N/A..............
(Also print name of signatory).......Bryan R Learmond...........................
Telephone and extension number.......0131 245 6839..............................
Note 1. Specify owner, not nominee or vehicle company. If relevant, also
identify controller of owner, eg where an owner normally acts on instructions of
a controller.
Note 2. Disclosure might be made for more than one reason; if so, state all
reasons.
Note 3. Specify which offeror if there is more than one.
Note 4. When an arrangement exists with any offeror, with the offeree company
or with an associate of any offeror or of the offeree company in relation to
relevant securities, details of such arrangement must be disclosed, as required
by Note 6 on Rule 8............................................................
...............................................................................
...............................................................................
For full details of disclosure requirements, see Rule 8 of the Code. If in
doubt, contact the Panel on Take-overs and Mergers, Tel. No: 0171-382 9026.
END
DCCZLGMKZDZLRMM
Celadon Pharmaceuticals (LSE:CEL)
Historical Stock Chart
From Jun 2024 to Jul 2024
Celadon Pharmaceuticals (LSE:CEL)
Historical Stock Chart
From Jul 2023 to Jul 2024